<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Cell. Mol. Med</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id><journal-id journal-id-type="publisher-id">JCMM</journal-id><journal-title-group><journal-title>Journal of Cellular and Molecular Medicine</journal-title></journal-title-group><issn pub-type="ppub">1582-1838</issn><issn pub-type="epub">1582-4934</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7171340</article-id><article-id pub-id-type="doi">10.1111/jcmm.15085</article-id><article-id pub-id-type="publisher-id">JCMM15085</article-id><article-categories><subj-group subj-group-type="overline"><subject>Corrigendum</subject></subj-group><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>Corrigendum</article-title></title-group><pub-date pub-type="epub"><day>20</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>4</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>24</volume><issue>7</issue><issue-id pub-id-type="doi">10.1111/jcmm.v24.7</issue-id><fpage>4362</fpage><lpage>4364</lpage><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 The Authors. <italic>Journal of Cellular and Molecular Medicine</italic> published by Foundation for Cellular and Molecular Medicine and John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JCMM-24-4362.pdf"/><related-article related-article-type="corrected-article" id="d37e75" ext-link-type="doi" xlink:href="10.1111/jcmm.14625">10.1111/jcmm.14625</related-article><counts><fig-count count="2"/><table-count count="0"/><page-count count="3"/><word-count count="510"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.1 mode:remove_FC converted:21.04.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="jcmm15085-body-0001"><p>In &#x02018;LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2&#x02019;, which was published in volume 23 issue 11, October <xref rid="jcmm15085-bib-0001" ref-type="ref">2019</xref>. The original article contains incorrect Figures <xref rid="jcmm15085-fig-0001" ref-type="fig">2</xref>D, <xref rid="jcmm15085-fig-0002" ref-type="fig">3</xref>C and F. The correct version of the figures is presented below.</p><fig fig-type="Figure" xml:lang="en" id="jcmm15085-fig-0001" orientation="portrait" position="float"><label>Figure 2</label><caption><p>LINC01133 knockdown promotes breast cancer cells migration, invasion and viability in vitro. A, qRT&#x02010;PCR analysis of LINC01133 expression in normal breast epithelial cell line (MCF&#x02010;10A) and human breast cancer cells. B, Relative expression of LINC01133 in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells after transfecting with LINC01133 shRNA compared with negative control (Nc). C, D, Wound&#x02010;healing assays were performed to assess cell migration following LINC01133 knockdown or Nc in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells. E, Transwell assays were performed to evaluate cell invasion following LINCO1133 knockdown or Nc in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells. F, G, CCK&#x02010;8 assay of LINC01133 knockdown (shRNAs) and NC breast cancer cells at indicated times</p></caption><graphic id="nlm-graphic-1" xlink:href="JCMM-24-4362-g001"/></fig><fig fig-type="Figure" xml:lang="en" id="jcmm15085-fig-0002" orientation="portrait" position="float"><label>Figure 3</label><caption><p>LINC01133 overexpression suppresses breast cancer cells migration, invasion and viability in vitro. A, Relative expression of LINC01133 in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells transfecting with vector for LINC01133 overexpression compared with vector Nc. B, C, Wound&#x02010;healing assays were performed to assess cell migration following LINC01133 overexpression or Nc in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells. D, Transwell assays were performed to evaluate cell invasion following LINCO1133 overexpression or NC in MDA&#x02010;MB&#x02010;231 and MCF&#x02010;7 cells. E, F, CCK&#x02010;8 assay of LINC01133 overexpression and NC breast cancer cells at indicated times</p></caption><graphic id="nlm-graphic-3" xlink:href="JCMM-24-4362-g002"/></fig></body><back><ref-list content-type="cited-references" id="jcmm15085-bibl-0001"><title>REFERENCE</title><ref id="jcmm15085-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jcmm15085-cit-0001">
<string-name>
<surname>Song</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>C</given-names>
</string-name>. <article-title>LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2</article-title>. <source xml:lang="en">J Cell Mol Med</source>. <year>2019</year>;<volume>23</volume>:<fpage>7554</fpage>&#x02013;<lpage>7565</lpage>.<pub-id pub-id-type="pmid">31557401</pub-id></mixed-citation></ref></ref-list></back></article>